Search for: "In Re: Asbestos Products Liab, et al" Results 1 - 18 of 18
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jun 2013, 6:43 pm by Schachtman
Martin, et al., New York Evidence Handbook  318 (2d ed. 2002)). [read post]
21 Jul 2014, 11:00 am by Schachtman
See, e.g., In re Silica Products Liab. [read post]
16 Mar 2011, 9:15 am by Schachtman
See In re Agent Orange Product Liab. [read post]
3 Mar 2012, 5:36 pm by Schachtman
Minn. 2008)(noting that some but not all courts have concluded relative risks under two support finding expert witness’s opinion to be inadmissible) XYZ, et al. v. [read post]
3 Feb 2019, 9:05 am by Schachtman
Rev. 983 (2005); Chris Michael Temple, “A Case for Why Silica Litigation Is Not the ‘Next Asbestos’,” Product Liab. [read post]
5 Jun 2013, 5:29 am by Schachtman
Supp. 247 (1984), rev’d on other grounds, 816 F.2d 1417 (10th Cir. 1987) In re TMI Litig., 927 F. [read post]
25 Apr 2015, 11:03 am by Schachtman
See also Manual at 614 n. 198., citing Ofer Shpilberg, et al., The Next Stage: Molecular Epidemiology, 50 J. [read post]
17 Oct 2021, 2:17 pm by admin
INTRODUCTION The new, third edition of the Reference Manual on Scientific Evidence was released to the public in September 2011, as a joint production of the National Academies of Science, and the Federal Judicial Center. [read post]
10 Jun 2017, 9:32 am by Schachtman
See, e.g., In re Zoloft (Sertraline Hydrochloride) Products Liability Litigation, U.S. [read post]
14 Nov 2011, 7:13 pm by Schachtman
  See Donna Stroup, et al., “Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting,” 283 J. [read post]
10 Jun 2012, 1:09 pm by Schachtman
Didham, et al., “Suicide and Self-Harm Following Prescription of SSRIs and Other Antidepressants: Confounding By Indication,” 60 Br. [read post]
14 Oct 2013, 6:08 am by Schachtman
Furthermore, their suggestion that Gauley Bridge fits into their Marxist paradigm of corporate corruption of science (citing similar works by Michaels, Castleman, Rosner, et al.) ignores the robust debate from all sectors of society, including the scientific community, organized labor, political actors, industry, government, and academia. [read post]